May 19, 2017 - By Clifton Ray
The stock of Kadmon Holdings Inc (NYSE:KDMN) is a huge mover today! About 51,495 shares traded. Kadmon Holdings Inc (NYSE:KDMN) has risen 6.00% since April 19, 2017 and is uptrending. It has by 0.00% the S&P500.The move comes after 5 months positive chart setup for the $126.86M company. It was reported on May, 19 by Barchart.com. We have $2.62 PT which if reached, will make NYSE:KDMN worth $5.07M more.
Corda Investment Management Llc increased Diageo Plc (DEO) stake by 30.7% reported in 2016Q4 SEC filing. Corda Investment Management Llc acquired 52,354 shares as Diageo Plc (DEO)’s stock 0.00%. The Corda Investment Management Llc holds 222,868 shares with $23.16 million value, up from 170,514 last quarter. Diageo Plc now has $74.32 billion valuation. The stock rose 0.62% or $0.74 reaching $120.77 per share. About 134,656 shares traded. Diageo plc (ADR) (NYSE:DEO) has risen 6.00% since April 19, 2017 and is uptrending. It has by 0.00% the S&P500.
Analysts await Kadmon Holdings Inc (NYSE:KDMN) to report earnings on June, 28. After $-0.50 actual EPS reported by Kadmon Holdings Inc for the previous quarter, Wall Street now forecasts 0.00% EPS growth.
Among 6 analysts covering Kadmon Holdings (NYSE:KDMN), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Kadmon Holdings had 6 analyst reports since August 22, 2016 according to SRatingsIntel. The rating was initiated by Jefferies with “Buy” on Monday, August 22. The rating was initiated by H.C. Wainwright on Monday, August 22 with “Buy”. The firm has “Outperform” rating given on Monday, August 22 by JMP Securities. The firm earned “Hold” rating on Thursday, March 16 by WBB Securities. The stock of Kadmon Holdings Inc (NYSE:KDMN) earned “Neutral” rating by Citigroup on Monday, August 22. Piper Jaffray maintained Kadmon Holdings Inc (NYSE:KDMN) rating on Friday, March 24. Piper Jaffray has “Overweight” rating and $23 target.
Kadmon Holdings, Inc. is an integrated biopharmaceutical firm engaged in the discovery, development and commercialization of small molecules and biologics to address disease areas of various unmet medical needs. The company has market cap of $126.86 million. The Firm is developing product candidates in a number of indications within autoimmune and fibrotic disease, oncology and genetic diseases. It currently has negative earnings. The Company’s product pipeline consists of KD025, Tesevatinib and KD034.
Among 22 analysts covering Diageo (NYSE:DEO), 14 have Buy rating, 3 Sell and 5 Hold. Therefore 64% are positive. Diageo had 30 analyst reports since July 31, 2015 according to SRatingsIntel. The stock has “Neutral” rating by Goldman Sachs on Tuesday, June 28. The stock has “Sell” rating by Goldman Sachs on Friday, March 31. The stock has “Neutral” rating by JP Morgan on Friday, July 31. The stock of Diageo plc (ADR) (NYSE:DEO) earned “Sell” rating by Liberum Capital on Monday, January 30. The stock has “Buy” rating by Sterne Agee CRT on Tuesday, July 21. The rating was downgraded by Deutsche Bank to “Hold” on Thursday, March 17. The company was maintained on Friday, July 31 by Barclays Capital. The firm has “Hold” rating given on Wednesday, September 23 by Shore Capital. The rating was maintained by Jefferies with “Buy” on Monday, April 24. The stock of Diageo plc (ADR) (NYSE:DEO) has “Buy” rating given on Friday, September 16 by Bank of America.
Corda Investment Management Llc decreased Whole Foods Market (NASDAQ:WFM) stake by 20,465 shares to 164,006 valued at $5.04 million in 2016Q4. It also reduced Spectra Energy Corp Com (NYSE:SE) stake by 13,821 shares and now owns 432,147 shares. Merck & Co Inc. Com (NYSE:MRK) was reduced too.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.